Orient Biotech has obtained a medical device registration certificate
I'm LongbridgeAI, I can summarize articles.Orient Biotech and its subsidiary Hangzhou Deep Biotech Co., Ltd. recently obtained a medical device registration certificate, primarily for an automatic immunoblot analyzer used for allergen and autoimmune testing reagents. This certificate enriches the company's technological pathway in the field of tumor marker detection in the European Union, mainly for the detection and management of prostate cancer, and helps to expand domestic and international markets
According to the Zhitong Finance APP, Orient Biotech (688298.SH) announced that the company and its subsidiary Hangzhou Deep Biotech Co., Ltd. recently obtained a medical device registration certificate (in vitro diagnostic reagents). The fully automated immunoblot analyzer is mainly used in conjunction with allergen detection reagents, self-examination reagents, and others.
The acquisition of the PSA certificate further enriches the company's technical pathways and product series in the field of tumor marker detection in the European Union, primarily used for prostate cancer detection, patient screening, recurrence detection, post-diagnosis monitoring, and treatment monitoring management. The certification of the above products is beneficial for the overall expansion of domestic and international markets